Chiara Pighi

Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies

Donato Amodio, Alessandra Ruggiero, Mayla Sgrulletti et al. · Frontiers in Immunology · 2021 · 95 citations · Full text

Ab Response, Immunodeficiencies, Humoral Response +19

Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells

Cristina Capuano, Maddalena Romanelli, Chiara Pighi et al. · Cancer Research · 2015 · 47 citations · Full text

Anti-cd20 Therapy Acts, Adaptive Immune System, Immune Regulation +24

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production

Cristina Capuano, Chiara Pighi, Rosa Molfetta et al. · OncoImmunology · 2017 · 40 citations · Full text

DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study

Chiara Focaccetti, Monica Benvenuto, Chiara Pighi et al. · Frontiers in Immunology · 2022 · 29 citations · Full text

Cell Therapy, Immunology, Nk Cells +20

Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming

Cristina Capuano, Simone Battella, Chiara Pighi et al. · Frontiers in Immunology · 2018 · 28 citations · Full text